Article

Louis Scampavia, PhD, associate professor in the Department of Molecular Therapeutics at the Scripps Research Institute in Florida, talks to contributing editor Tanuja Koppal, PhD, about how automation has been a critical part of their high-throughput screening activities. He goes into the details of what can and should be automated and the due diligence that needs to be performed before these decisions are made—decisions that have a long-standing impact on the workings of a lab.

Using a smartphone to cram in more work at night results in less work the next day, indicates new research co-authored by a Michigan State University business scholar.

















